Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm, 2005; 292:29–41. https://doi.org/10.1016/j.ijpharm.2004.08.019 | | Anusha P, Nirajana A, Mohammed S, Jilani S, Murali C, Harish G. Development and evaluation of drotaverine taste masked tablets with improved dissolution efficiency using sold dispersion technique. IJRPB, 2013; 1:275–80. | | | Ashwini M, Shivajirao K, Varsha P. Studies on formulation development of mucoadhesive sustained release itraconazole tablet using response surface methodology. AAPS Pharm Sci Tech, 2008; 9:998–1005. https://doi.org/10.1208/s12249-008-9119-8 | | | Bi YX, Sunada H, Yonezawe Y, Danzo K. Evaluation of rapidly disintegrating tablets. Drug Dev Ind Pharm, 1999; 25:571–81. https://doi.org/10.1081/DDC-100102211 | | | Craick DJ. The flow properties of starch powders and mixtures. J Pharm Pharmacol 1958; 10:10. https://doi.org/10.1111/j.2042-7158.1958.tb10275.x | | | Indian Pharmacopoeia. Govt of India, Ministry of Health and Family Welfare, the Indian Pharmacopeia Commission, Ghaziabad, India, pp 187–93, 2010. | | | Katsuno E, Tahara K, Takeuchi Y, Takeuchi H. Orally disintegrating tablets prepared by a co-processed mixture of micronized crospovidone and mannitol using a ball mill to improve compatibility and tablet stability. Powder Technol, 2013; 241:60–6. https://doi.org/10.1016/j.powtec.2013.03.008 | | | Kumar R, Patil S, Patil MB, Patil SR, Paschapur MS. Formulation evaluation of mouth dissolving tablets of fenofibrate using sublimation technique. Int J Chem Tech Res, 2009; 1:840–50. | | | Pandey B, Mallik S, Ahmad S. Coprocessing of super disintegrants for drug release of taste masked Drotaverine HCl. Novel Sci IJPS, 2012; 1:758–63. | | | Pankaj A, Sanjay P, Abhijeet T, Manoj W, Parag K, Rajendra S. Design and evaluation of taste masked chewable dispersible tablet of lamotrigine by melt granulation. Int J Drug Delivery, 2010; 2:183–91. https://doi.org/10.5138/ijdd.2010.0975.0215.02028 | | | Raghavendra N, Mahesh K, Srikanth M, Kistayya C, Mahipal B. Development and evaluation of fast dissolving tablets of fosinopril by sublimation method. Int J Pharm Sci Drug Res, 2012; 4:230–35. | | | Sivaprasad S, Hindustan A, Sreenivasulu R, Kishore R, Krishna CH, Kranthi G, et al. Novel approach in designing of mouth dissolving tablets for bitter drugs taking clozapine as model drug. Der Pharmacia Lett, 2011; 3:113–20. | | | Srikanth M, Uhumwangho M, Sunil S, Sreenivasa N, Ravi C, Ramana Murthy K. Design and evaluation of taste masked Drotaverine HCl orodispersible tablets using polymethacrylate polymers. Der Pharmacia Lett, 2010; 2:223–31. | | | Subrahmanian S, Sankar V, Asha A. Formulation and evaluation of cetirizine dihydrochloride orodispersible tablet. Pak J Pharm Sci, 2010; 23:232–35. | | | Tran D. Some aspects of the property of angle of repose of powders. J Pharm Pharmacol, 1957; 1:127–35. | | | Uchida T, Nakamura T, Tanigake A. The effect of various substances on the suppression of the bitterness of quinine-human gustatory sensation, binding and taste sensor studies. Chem Pharm Bull (Tokyo), 2002; 50:1589–93. https://doi.org/10.1248/cpb.50.1589 | | | Uddhav B, Kishore G, Nancy P, Sanjeevani A, Shalaka D. Formulation and evaluation of sublimed fast melt tablets of levocetirizine dihydrochloride. IJPSR, 2010; 2:76–80. | | | Ujwala B, Dinesh S, Sarika Z, Varsha K, Nanda R. Development and evaluation of drotaverine taste masked tablets with improved dissolution efficiency using sold dispersion technique. Res J Pharm Tech, 2014; 7:301–6. | | | USP30-NF25. The official compendia of standards. The United States Pharmacopoeial Convention. Powder flow (e book), 2007; 643. | | | USP30-NF25. The official compendia of standards. The United States Pharmacopoeial Convention. Bulk Dens Tapped Dens (e book), 2007; 242. | | | Yoshinari T, Forbes RT, York P, Kawashima Y. Moisture induced polymorphic transition of mannitol and its morphological transformation. Int J Pharm, 2002; 247:69–77. https://doi.org/10.1016/S0378-5173(02)00380-0 | | |
|